Mr. Yuji Kageyama will be newly appointed as Outside Director effective June 25, 2026, and Mr. Yasmaru Tokiwa is scheduled to assume the position of Full-time Audit & Supervisory Committee Member. An organizational reform will be implemented with the establishment of the SI Business Promotion Office effective April 1, 2026.
As of April 1, 2026, ORIX Corporation implemented multiple executive personnel changes including the President and CEO, as well as organizational reform in the Infrastructure Business Division.
Changes in executive officers and directors to take effect on April 1, 2026, and June 26, 2026. Through organizational reforms, new domains and position changes will be made to strengthen the management structure.
Significant changes in directors and executive officers as well as organizational reforms will be implemented, including a change of Representative Director and President, transition of the executive officer system to a delegated type, and introduction of a new Group Executive Officer system, effective at the regular shareholders meetings held on April 1 and June 2026.
Kobayashi Pharmaceutical provides a detailed report on the progress of recurrence prevention measures for quality issues related to red yeast rice products, promoting strengthening of a quality and safety-first system and organizational culture reform.
SUBARU will implement organizational reforms and executive changes effective April 1, 2026 and June 2026. Through the establishment of new divisions and appointment of new executives, the company aims to strengthen the execution system.
Established the Culture Transformation Lab as of February 1, 2026, with Executive Officer Masayuki Minai's position change and Shinichi Kishida appointed as Chief of the Culture Transformation Lab in personnel changes.